Erez Capital Announces Additional Venture Partners
BOSTON, Aug 4, 2023 – (ACN Newswire) – Erez Capital, an emerging venture capital fund…
BOSTON, Aug 4, 2023 – (ACN Newswire) – Erez Capital, an emerging venture capital fund…
Revenue Up 111% over 2021 MIAMI & TORONTO–(BUSINESS WIRE)–$PAID #Fintech—XTM, Inc. (“XTM” or the “Company”)…
Fisker showcases vision for sustainable all-electric vehicle lineup through 2026. Vehicles include Ronin, PEAR, Alaska,…
NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced…
Vancouver, British Columbia–(Newsfile Corp. – August 3, 2023) – Telescope Innovations Corp. (“Telescope” or the…
SAN DIEGO, CA, Aug 4, 2023 – (ACN Newswire) – On Aug. 1, 2023, General…
DALLAS, TX, Aug 4, 2023 – (ACN Newswire) – Armor, a leading cybersecurity company providing…
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–All amounts are in U.S. Dollars unless otherwise indicated: SECOND QUARTER HIGHLIGHTS…
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage…
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage…
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons FOSTER CITY, Calif., Aug….
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons FOSTER CITY, Calif., Aug….
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…